Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Artificial Blood Vessels Market size was over USD 2.1 billion in 2024 and is estimated to reach USD 4.6 billion by the end of 2037, expanding at a CAGR of 9% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of artificial blood vessels is evaluated at USD 2.3 billion.
The increasing prevalence of cardiovascular disease (CVD) and diabetes-related complications is the primary driver behind the growth of the artificial blood vessels market. In this regard, the WHO reported that the number of ischemic heart disorders (IHD) around the world surpassed 500.3 million in 2024. Further, in 2025, the European Centre for Disease Prevention and Control (ECDC) calculated the total number of CVD-afflicted people alone in Germany to be 2.5 million, which showcased a 14.2% growth from 2020. This enlarging demography presents a sustainable demand worldwide for associated interventional components, including vascular grafts, pushing both MedTech pioneers and healthcare authorities to invest in this sector.
Excessive financial exhaustion has always been a root cause of this disparity, which is inflated by cost volatilities in the raw material supply chains, production, and regulatory compliance. Thus, the magnifying economic burden on patients is currently a significant issue to resolve for leaders in the artificial blood vessels market. This can be displayed through the upward trajectory of payer's pricing in different stages of conducting business operations. For instance, in 2023, the producer price index (PPI) for surgical appliances rose by 6.9% year-over-year (YoY). This was caused by the disruptions in sourcing medical-grade polymer during the pandemic, reflecting an overall 12.3% increase in producer price. Subsequently, the consumer price index (CPI) for surgical implants grew by 4.4%.
